Press Releases Precipio, Inc.

Equities

PRPO

US74019L6020

Real-time Estimate Cboe BZX Other stock markets 02:35:54 2024-04-29 pm EDT			5-day change	1st Jan Change
5.97 ^USD	-0.91%		-5.53%	-8.00%

Apr. 01	Transcript : Precipio, Inc. - Special Call
Mar. 29	Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Precipio Announces Year end 2023 Shareholder Update Call	Mar. 25	AQ
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY	Feb. 13	AQ
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer	Feb. 06	AQ
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter	Jan. 23	AQ
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	Jan. 17	AQ
Precipio Announces Christina Valauri joins the Board of Directors	Jan. 02	AQ
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024	Dec. 14	AQ
Precipio Announces Q3-2023 Shareholder Update Call	Nov. 16	AQ
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022	23-10-18	AQ
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023	23-10-03	AQ
Precipio Continues to Sign New HemeScreen™ Customers	23-09-28	AQ
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven	23-09-25	AQ
Precipio Takes Final Step Towards Regaining Nasdaq Compliance	23-09-21	AQ
Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan	23-09-13	AQ
Precipio Announces Q2-2023 Shareholder Update Call	23-08-10	AQ
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel	23-08-08	AQ
Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven	23-08-03	AQ
Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023	23-08-01	AQ
PRECIPIO, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-15	AQ
Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy	23-06-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Precipio, Inc.

Equities

PRPO

US74019L6020

Press Releases

Filters